Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Mr. Tajinder S. Vohra

Senior Vice President of Global Operations

Ms. Miriame  Victor

Senior Vice President & Chief Commercial Officer

Mr. Andrew  Okun

Vice President, Chief Accounting Officer & Treasurer

Dr. Prahlad R. Singh Ph.D.

Chief Executive Officer, President & Director

Ms. Jayashree  Thacker

Senior Vice President & Global Chief Information Officer

Mr. Arvind  Sundar-Rajan

Vice President of Digital & Technology

Mr. Joel S. Goldberg

Senior Vice President of Administration, General Counsel & Secretary

Mr. Maxwell  Krakowiak

Senior Vice President & Chief Financial Officer

Ms. Madhuri  Hegde FACMG, Ph.D.

Senior Vice President & Chief Scientific Officer

Mr. Stephen Barr Willoughby

Senior Vice President of Investor Relations & Head of ESG

Pavadinimas	Rinkos kapitalizacija
China Health Group Inc.	0M
Standard BioTools Inc.	0M
IDEXX Laboratories, Inc.	0M
China Biotech Services Holdings Limited	0M
Sonic Healthcare Limited	0M
Quest Diagnostics Incorporated	0M
Qiagen N.V.	0M
Amoy Diagnostics Co., Ltd.	0M
WuXi AppTec Co., Ltd.	0M
Genetic Technologies Limited	0M

Revvity, Inc.

Revvity, Inc. Konkurentų sąrašas

Pagrindiniai konkurentai